BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Bacillus coagulans R11 maintained intestinal villus health and decreased intestinal injury in lead-exposed mice by regulating the intestinal microbiota and influenced the function of faecal microRNAs. ✅
Go to Publication ✅
Environmental pollution (Barking, Essex : 1987) (Environ Pollut ) Vol: 255 Issue Pt 2 Pages: 113139 Pub: 2019 Sep 13 Epub: 2019 Sep 13 Authors Xing SC , Huang CB , Mi JD , Wu YB , Liao XD , |
|
|
Bacillus coagulans regulates gut microbiota and ameliorates the alcoholic-associated liver disease in mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1337185 Pub: 2024 Epub: 2024 Feb 26 Authors Liu Z , Liu T , Zhang Z , Fan Y , |
|
|
Effects of Bacillus coagulans TBC169 on gut microbiota and metabolites in gynecological laparoscopy patients. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1284402 Pub: 2024 Epub: 2024 Mar 26 Authors Gao W , Yan Y , Guan Z , Zhang J , Chen W , |
|
|
Bacillus coagulans MZY531 alleviates intestinal mucosal injury in immunosuppressive mice via modulating intestinal barrier, inflammatory response, and gut microbiota. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 13 Issue 1 Pages: 11181 Pub: 2023 Jul 10 Epub: 2023 Jul 10 Authors Zhao Z , Sun M , Cui X , Chen J , Liu C , Zhang X , |
|
|
Bacillus coagulans SANK 70258 suppresses Enterobacteriaceae in the microbiota of ulcerative colitis in vitro and enhances butyrogenesis in healthy microbiota. ✅
Go to Publication ✅
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 104 Issue 9 Pages: 3859-3867 Pub: 2020 May Epub: 2020 Mar 7 Authors Sasaki K , Sasaki D , Inoue J , Hoshi N , Maeda T , Yamada R , Kondo A , |
|
|
Bacillus coagulans SANK 70258 suppresses Enterobacteriaceae in the microbiota of ulcerative colitis in vitro and enhances butyrogenesis in healthy microbiota. ✅
Go to Publication ✅
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 104 Issue 9 Pages: 3859-3867 Pub: 2020 May Epub: 2020 Mar 7 Authors Sasaki K , Sasaki D , Inoue J , Hoshi N , Maeda T , Yamada R , Kondo A , |
|
|
Weizmannia coagulans BC99 Enhances Intestinal Barrier Function by Modulating Butyrate Formation to Alleviate Acute Alcohol Intoxication in Rats. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 23 Pages: Pub: 2024 Nov 29 Epub: 2024 Nov 29 Authors Li C , Zhai S , Duan M , Cao L , Zhang J , Wang Y , Wu Y , Gu S , |
|
|
Bacillus coagulans and Clostridium butyricum synergistically alleviate depression in a chronic unpredictable mild stress mouse model through altering gut microbiota and prefrontal cortex gene expression. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1393874 Pub: 2024 Epub: 2024 May 23 Authors Xu J , Zhou L , Chen Z , Wang Y , Xu F , Kuang Q , Zhang Y , Zheng H , |
|
|
Impact of Heyndrickxia (Bacillus) coagulans GBI-30, 6086 (BC30) probiotic on gastrointestinal function in healthy adults: a randomised controlled trial. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: Issue Pages: 1-18 Pub: 2025 Jul 22 Epub: 2025 Jul 22 Authors Gang H , Wei J , McFarland LV , Zahra R , Saez ME , Blanco-Rojo R , Millette M , |
|
|
Weizmannia coagulans BC99 alleviates pediatric allergic rhinitis via the gut microbiota-SCFAs- immunomodulatory axis: A randomized, double-blind, placebo-controlled trial. ✅
Go to Publication ✅
International immunopharmacology (Int Immunopharmacol ) Vol: 168 Issue Pt 1 Pages: 115787 Pub: 2025 Nov 5 Epub: 2025 Nov 5 Authors Han Z , Zhu H , Yang Y , Wang Y , Li X , Zhu J , Wu Y , Fang S , Gu S , |
|
|
Supplementation of Bacillus coagulans and Tributyrin to Danzhou Chickens: Effects on Growth Performance, Antioxidant Status, Immune Response, Intestinal Health, and Cecal Microbiome. ✅
Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 15 Issue 23 Pages: Pub: 2025 Nov 27 Epub: 2025 Nov 27 Authors Yu X , Xu F , Zhao D , Chai H , Yu Y , Peng W , Xu L , Wu H , |
|
|
Effects of dietary supplementation with Bacillus coagulans on growth and immune performance, rumen microorganisms, and metabolites of yaks. ✅
Go to Publication ✅
BMC microbiology (BMC Microbiol ) Vol: 25 Issue 1 Pages: 789 Pub: 2025 Dec 8 Epub: 2025 Dec 8 Authors Zhang C , Luosan D , La Y , Ma X , Wu X , Chu M , Guo X , Pincuo Z , Liang C , |
|
|
Effects of adding Bacillus coagulans to the diet on diarrhea, gut microbiota, and metabolites in yak. ✅
Go to Publication ✅
BMC veterinary research (BMC Vet Res ) Vol: Issue Pages: Pub: 2025 Dec 16 Epub: 2025 Dec 16 Authors Zhang C , Luosan D , La Y , Ma X , Wu X , Chu M , Guo X , Pincuo Z , Liang C , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
